Ruxolitinib, Free base
Ruxolitinib is a potent and selective Janus kinase (JAK) inhibitor with with IC₅₀'s of 2.7 and 4.5 nM for JAK1 and JAK2, respectively. Displays clinically significant activity in myelofibrosis.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
24months
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC214639L2V 200 µL
MALT1 (NM_006785) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details MBS7083810 Inquire
Recombinant Xenopus laevis Post-GPI attachment to proteins factor 2 (pgap2), partial
Sign In for Pricing
View Details 